Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center

26Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The value of re-exploration for pancreatic ductal adenocarcinoma after the initial diagnosis of unresectability is unclear. Methods: In this study, we analyzed 33 patients who were re-explored after an initial diagnosis of unresectability. Results: At the time of reoperation, a resectable tumor was found in 18 patients: therefore, 15 pancreaticoduodenectomies, two total pancreatectomies and one left resection were performed with three vascular resections. Morbidity and mortality rates for the cohort were 6/33 and 1/33, without significant differences between resectable and nonresectable patients. Length of stay, duration of operation, and blood loss were significantly increased in the resection group. Kaplan-Meier survival analysis demonstrated increased median survival for resected patients (1078 days after the initial operation versus 547 days in the group of unresectable patients; p = 0.018). Analysis of the reasons against initial resection showed that, if the patients had been sent to a tertiary referral center for pancreatic surgery, a different decision in favor of resection would probably have been made in 14 out of 33 patients. A review of 10 published reports on reoperation for pancreatic cancer revealed results comparable to our study in terms of low morbidity and mortality as well as a survival benefit. Conclusions: Reoperation for pancreatic ductal adenocarcinoma that is initially deemed unresectable can be safely performed in a selected group of patients by experienced surgeons, supporting the concept of patient centralization in pancreatic surgery. Resection at the second operation may confer a survival benefit even when the initial findings preclude a potentially curative approach. © 2007 The Author(s).

References Powered by Scopus

Hospital volume and surgical mortality in the United States

4442Citations
N/AReaders
Get full text

Surgeon Volume and Operative Mortality in the United States

2826Citations
N/AReaders
Get full text

One thousand consecutive pancreaticoduodenectomies

1111Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality

277Citations
N/AReaders
Get full text

The "Artery First" Approach for Resection of Pancreatic Head Cancer

229Citations
N/AReaders
Get full text

Resection of primary pancreatic cancer and liver metastasis: A systematic review

90Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Michalski, C. W., Kleeff, J., Bachmann, J., Alkhatib, J., Erkan, M., Esposito, I., … Büchler, M. W. (2008). Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center. Annals of Surgical Oncology, 15(1), 186–192. https://doi.org/10.1245/s10434-007-9535-0

Readers over time

‘10‘12‘13‘14‘15‘16‘17‘19‘20‘21‘22‘2301234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

57%

Professor / Associate Prof. 5

22%

Researcher 4

17%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

84%

Nursing and Health Professions 1

5%

Social Sciences 1

5%

Agricultural and Biological Sciences 1

5%

Save time finding and organizing research with Mendeley

Sign up for free
0